Use of STAMP-seq to enable spatial transcriptomics through single-nucleus in situ tagging and exploration of relationship of dynamic plasma cell modules and immunotherapy response in non-small cell lung cancer.

Y Yitong Pan (Center for Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University) H Huan Yan J Jinhuan Han (SeekGene BioSciences Co. Ltd, Beijing, Beijing, China) R Rui Wu (Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, China.) X Xingyong Ma (SeekGene BioSciences Co. Ltd, Beijing, Beijing, China) Y Ying Guan K Keyu Li (Department of Pharmacy, The First Affiliated Hospital of the University of Science and Technology of China, and State Key Laboratory of Precision and Intelligent Chemistry) Q Qingquan Wei G Guangxin Zhang S Shaozhuo Jiao Y Yongchang Zhang C Chenxi Tian

Abstract

e20040 Background: Immunotherapy has revolutionized cancer treatment, particularly in non-small cell lung cancer (NSCLC), yet a large fraction of patients remain refractory to treatment. Understanding treatment response requires characterization of immune cell populations and their spatial organization, as cellular neighborhoods critically influence immune cell recruitment, activation, and function. Current imaging-based and NGS-based methods struggle to achieve clear separation of individual cells in densely packed regions. Hence, we developed STAMP-seq, a novel method tagging single nuclei with cleavable spatial barcodes using high-density DNA sequencing chips, to uncover immunotherapy response-related modules and dynamic changes in NSCLC. Methods: STAMP-seq employs spatially-encoded DNA arrays to label individual nuclei with cleavable barcodes. Following validation in mouse brain tissue, we analyzed surgically resected NSCLC samples from immunotherapy-treated patients, integrating spatial transcriptomics with BCR profiling to characterize treatment response features. Results: STAMP-seq achieves precise spatial barcoding, detecting over 30,000 cells per adult mouse brain section with reliable cell subtype assignment. In immunotherapy-treated NSCLC samples, spatial analysis revealed distinct cellular communities associated with treatment response. Responding patients showed enrichment of tertiary lymphoid structures and specialized plasma cell niches, with tumor cells exhibiting elevated TNF-α signaling and reduced proliferation. These tumor cells showed proximity to ROBO2 + CAFs while remaining distant from ACTA2 + CAFs. BCR clonotype and pseudotime analysis revealed that IGHG1 + plasma cells are recruited from TLS or vasculature by stromal-rich "transit stops" containing antigen-presenting capabilities CAFs through HMGB1 - CXCR4 interaction. Conclusions: STAMP-seq enables high-resolution spatial transcriptomics at single-nucleus level. Our characterization of NSCLC spatial architecture revealed previously unrecognized immune response organization, particularly how specialized stromal-rich "transit stops" coordinate cancer-suppressing plasma cell recruitment. These findings demonstrate how spatial information can advance diagnostic and prognostic module development for human diseases.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (12)

Y

Yitong Pan

Center for Molecular Oncology, Frontiers Science Center for Disease-related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University

H

Huan Yan

J

Jinhuan Han

SeekGene BioSciences Co. Ltd, Beijing, Beijing, China

R

Rui Wu

Beijing National Laboratory for Condensed Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, China.

X

Xingyong Ma

SeekGene BioSciences Co. Ltd, Beijing, Beijing, China

Y

Ying Guan

K

Keyu Li

Department of Pharmacy, The First Affiliated Hospital of the University of Science and Technology of China, and State Key Laboratory of Precision and Intelligent Chemistry

Q

Qingquan Wei

G

Guangxin Zhang

S

Shaozhuo Jiao

Y

Yongchang Zhang

C

Chenxi Tian